Clinicopathological analysis showed that lower expression of HOXA11‐AS was remarkably linked with tumor size, advanced tumor‐node‐metastasis stage, lymphnode metastasis as well as carcinoembryonic antigen level of patients with CRC. The gene discussed is CEACAM5; the disease is neoplasm.